Lymphatic disorders caused by mosaic, activating KRAS variants respond to MEK inhibition

Sarah E. Sheppard(Genomics (United Kingdom)), Håkon Håkonarson(Children's Hospital of Philadelphia)
JCI Insight
May 7, 2023
Cited by 36


Related Papers